HALOBETASOL PROPIONATE | N208183 | LACER PHARMA LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Sun Pharmaceutical Industries, Inc. et al v. Perrigo Company et al 1 patentANDA 211464halobetasol propionate | W.D. Mich. | 2018-05-10 | Terminated 2018-08-24 | — |
Sun Pharmaceutical Industries, Inc. et al v. Perrigo Company et al 1 patentANDA 211464halobetasol propionate | D. Del. | 2018-05-09 | Terminated 2020-03-11 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lachman Consultants Services, Inc FDA-2017-P-4194 · 3 docket documents Lachman Consultants Services, Inc. filed this citizen petition requesting that the FDA designate either Halobetasol Propionate Ointment 0.05% held by Perrigo Israel Pharmaceuticals Ltd under ANDA A076872 or Halobetasol Propionate Ointment 0.05% held by G and W Laboratories Inc under ANDA A077721 as | 505(q) | 2017-07-14 | Withdrawn | Lachman Consultants Services, Inc |
Source: Regulations.gov. FDA citizen petitions matched by application number.
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8962028 | Jun 19, 2033 | — | — | Yes | — |